📰 Amina Odidi News
Amina Odidi News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amina Odidi. Real-time updates on events, politics, business and more.
October 16, 2023
MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 The...
October 6, 2023
Intellipharmaceutics Reports Director Election Results Toronto, Ontario, September 14, 2023, Intellipharmaceutics International Inc. , a pharmaceutical company specializing in...
October 6, 2023
Appointment of Proxyholder I/We, being holder of common shares of Intellipharmaceutics International Inc. , hereby appoint of Dr. Amina Odidi, President and Chief Operating...
September 26, 2023
MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS For the THREE MONTHS ENDED February 28, 2023 The following...
September 14, 2023
Intellipharmaceutics Reports Director Election Results
May 27, 2022
TORONTO, ON / ACCESSWIRE / May 27, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research
February 5, 2022
TORONTO, ON / February 4, 2022 / Intellipharmaceutics International Inc. and , a pharmaceutical company specializing in the research, development and manufacture of novel and generic... | February 4, 2022
February 4, 2022
Press release content from Accesswire. The AP news staff was not involved in its creation.
December 23, 2020
Intellipharmaceutics International Inc.: Intellipharmaceutics Reports Director Election Results TORONTO, ON / ACCESSWIRE / December 23, 2020 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) (TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, reports, as required by TSX rules, that the six nominees, each of whom was an i...